<jats:title>Abstract</jats:title><jats:p>The incorporation of new‐to‐nature extender units into polyketide synthesis is an important source for diversity yet is restricted by limited availability of suitably activated building blocks in vivo. We here describe a straightforward workflow for the biogenic activation of commercially available new‐to‐nature extender units. Firstly, the substrate scope of a highly flexible malonyl co‐enzyme A synthetase from <jats:italic>Streptomyces cinnamonensis</jats:italic> was characterized. The results were matched by in vivo experiments in which the said extender units were accepted by both the polyketide synthase and the accessory enzymes of the monensin biosynthetic pathway. The experiments gave rise to a series of predictable monensin derivatives by the exploitation of the innate substrate promiscuity of an acyltransferase and downstream enzyme functions.